







Occupational hearing loss (OHL) may occur when workers are exposed to 
loud noise and/or ototoxic chemicals such as heavy metals, organic solvents, 
and asphyxiants. Approximately 22 million workers in the United States are 
exposed to hazardous noise each year, of whom 1 8 %  have hearing loss. 
Surveillance is vital for preventing OHL. The establishment of prevalence and 
incidence estimates of hearing loss within industries is made possible through 
surveillance. It also enables researchers and others to identify high-risk 
groups, guide prevention and research efforts, and evaluate the success or 
failure of interventions.
The National Institute for Occupational Safety and Health (NIOSH) initiated 
the OHL Surveillance Project in 2009 to develop a national surveillance 
system for OHL. The project uses a novel approach to data collection by 
partnering with audiometric service providers to collect de-identified 
worker audiograms and related data. This approach allows NIOSH to collect 
millions of de-identified audiograms from thousands of workplaces across 
the United States while protecting the identities of workers, companies, and 
providers. NIOSH then performs OHL surveillance and research. Findings are 
available for use by policy makers, researchers, workers, employers, and other 
stakeholders.
As of 2012, NIOSH has partnered with 16 audiometric service providers, 
and over 8.7 million de-identified audiograms have been collected.
Data collection, statistical analyses, and dissemination of research results 
are ongoing. Project results indicate workers in mining, construction, and 
manufacturing have the highest risks for hearing loss, but no industry can 
be assumed 'safe' from exposures that damage hearing, including noise and 
ototoxic chemicals.
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